Lyka Labs Limited
₹87.79▲ +4.18 (+5.00%)
LYKALABS·NSE·Healthcare
Market Cap
318.22 Cr
PE Ratio
-32.30
Volume
47,097
Day High - Low
87.79 - 87.79
52W High-Low
98.90 - 44.10
₹87.79▲ +4.18 (+5.00%)
Market Cap318.22 Cr
PE Ratio-32.30
Volume47,097
Day High - Low87.79 - 87.79
52W High-Low98.90 - 44.10
Lyka Labs Limited (LYKALABS): company summary
The company's annual revenue fell 6.9% to ₹128 crore, while annual net profit swung to a loss of ₹10 crore from a profit of ₹8 crore.
Lyka Labs Limited (LYKALABS) is a micro-cap Healthcare company valued at ₹318 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Lyka Labs Limited last traded at ₹87.79, sharply up 5.00% on the day.
- Recent developments
- On 2026-06-30, the company reported a net loss of ₹10 crore for the fiscal year ending March 2026, compared to a profit of ₹8 crore in the previous fiscal year. Promoter holding increased by 0.29 percentage points to 58.45% as of June 2026.
- Financial performance
- The company's annual revenue fell 6.9% to ₹128 crore, while annual net profit swung to a loss of ₹10 crore from a profit of ₹8 crore. The latest quarter saw revenue rise 28.1% to ₹42 crore and net profit jump 107.1% to ₹2 crore compared to the same quarter a year earlier.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 3.27 times book value.
- Things to watch
- The company reported a net loss of ₹10 crore in the latest fiscal year, compared to a profit of ₹8 crore in the prior year. Net profit margin fell to -8.1% from 5.8% a year earlier. The stock is 19.2% below its 52-week high.
- Where it stands
- The company ended the latest fiscal year with a net loss of ₹10 crore, while the latest quarter saw net profit rise to ₹2 crore. The stock is 19.2% below its 52-week high.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
3.3/10
Poor
Fair Value
Sign in to see
ROE
-10.86%
Weak
P/E
-32.30x
Loss-making
Debt / Equity
0.52
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
52W₹44.10
₹98.90
DocStoX take
Supported by momentum (7.5), but held back by quality (1.0). Momentum looks strong at 7.5, but that is offset by quality at 1.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence3.3
/10
Poor
Quality
Weak
ROE -10.9%
Valuation
Rich
P/B 3.3× on assets (no earnings to value)
Growth
Slow
Revenue +8.3% 5Y CAGR
Risk
Elevated
D/E 0.52
Momentum
Strong
80% of 52-week range
At a glance
Market Cap
₹318 Cr
52W High / Low
₹99 / ₹44
Dividend Yield
0.00%
Promoter Holding
58.45%
EPS (TTM)
₹-2.81
Book Value
₹25.89
Key highlights
- Loss-making — no meaningful P/E
- Loss-making in some of the last 5 years
0 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Lyka Labs Limited’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Lyka Labs Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Lyka Labs Limited with peers
Lyka Labs Limited vs Sun Pharmaceutical Industries LimitedLyka Labs Limited vs Divi's Laboratories LimitedLyka Labs Limited vs Torrent Pharmaceuticals LimitedLyka Labs Limited vs Apollo Hospitals Enterprise LimitedLyka Labs Limited vs Zydus Lifesciences LimitedLyka Labs Limited vs Laurus Labs Limited
Related tools & concepts
Value Lyka Labs Limited with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing